Evidence map›Paper›PMID 30105761›Full record

SynthesisActa psychiatrica Scandinavica2019

Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia.

I Arican, N Bass, K Neelam, K Wolfe, A McQuillin, G Giaroli

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Acta psychiatrica Scandinavica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

I AricanMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.ORCID 0000-0002-2736-0255
N BassMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.
K NeelamGreater Manchester Mental Health NHS Foundation Trust, Bolton, UK.
K WolfeMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.
A McQuillinMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.
G GiaroliMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.
University College London · GBGreater Manchester Mental Health NHS Foundation Trust · GB

Funding

BRCMedical Research Council PhD studentship MR/K501268-1NIHRUCLH
6 · The paper itself

Abstract

objectiveTo investigate the frequency of childhood and adult attention deficit hyperactivity disorder (ADHD) symptoms in a cohort of patients with schizophrenia (SCZ).

methodsA systematic review was conducted to evaluate existing evidence. Two self-report questionnaires were used to investigate adult ADHD and childhood ADHD symptoms in 126 patients with ICD-10 diagnoses of SCZ.

resultsFive studies were included in the systematic review, with the prevalence of childhood and adult ADHD in SCZ subjects ranging between 17-57% and 10-47% respectively. Within our cohort, 47% of patients reported positive screening for ADHD symptoms either in childhood or adulthood. 23% reported symptomatology consistent with both childhood and adult ADHD.

conclusionsWe demonstrate a greater presence of ADHD symptomatology in SCZ compared to that reported for ADHD in the general population. Our findings highlight the importance of improved clinical assessment and treatment considerations in a subgroup of patients with SCZ.

Indexed as

AdolescentAdultAgedAttention Deficit Disorder with HyperactivityCognitive DysfunctionCohort StudiesComorbidityFemaleHumansMaleMass ScreeningMiddle AgedPrevalenceSchizophreniaSelf ReportSurveys and QuestionnairesADHDcognitive impairmentcomorbiditydiagnosispsychoses

Identifiers

PMID30105761
PMCPMC6412852
OpenAlexW2885142997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.